PillHydroxychloroquine Sulfate
Brands: Sovuna · Hydroxychloroquine Sulfate
23 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 23 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it23 active · 1 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Bryant Ranch Prepack | repackager | 36 | SUPPLYING |
| A-S Medication Solutions | unknown | 8 | SUPPLYING |
| Dr.Reddy's laboratories Limited | unknown | 8 | SUPPLYING |
| ANI Pharmaceuticals, Inc. | unknown | 5 | SUPPLYING |
| Asclemed USA, Inc. | unknown | 5 | SUPPLYING |
| Aphena Pharma Solutions - Tennessee, LLC | unknown | 5 | SUPPLYING |
| Rising Pharma Holdings, Inc. | unknown | 4 | SUPPLYING |
| Ipca Laboratories Limited | unknown | 4 | SUPPLYING |
| Laurus Labs Limited | unknown | 4 | SUPPLYING |
| Zydus Pharmaceuticals USA Inc. | unknown | 3 | SUPPLYING |
| Amneal Pharmaceuticals LLC | unknown | 3 | SUPPLYING |
| Zydus Lifesciences Limited | unknown | 3 | SUPPLYING |
| Preferred Pharmaceuticals Inc. | unknown | 2 | SUPPLYING |
| Aurobindo Pharma Limited | unknown | 2 | SUPPLYING |
| NorthStar Rx LLC | unknown | 2 | SUPPLYING |
+ 9 more labelers
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Jan 5, 2026RESOLVEDShortage resolved: Hydroxychloroquine Sulfate Tablet (Teva Pharmaceuticals USA, Inc.)
Hydroxychloroquine Sulfate Tablet — reported in shortage by Teva Pharmaceuticals USA, Inc.. Therapeutic category: Anti-Infective, Other, Rheumatology.
- Jan 5, 2026SHORTAGEDrug shortage: Hydroxychloroquine Sulfate Tablet (Teva Pharmaceuticals USA, Inc.)
Hydroxychloroquine Sulfate Tablet — reported in shortage by Teva Pharmaceuticals USA, Inc.. Therapeutic category: Anti-Infective, Other, Rheumatology.